Partnerships

Market Access

Capital discipline in biotech: Building enduring companies w...

Capital depends on the strength of the science, the quality of execution, and the ability to deliver on milestones as planned.

R&D

Closed & Collaborative H2 2025: Mergers, acquisitions, partn...

The second half of 2025 showed pharma and healthcare leaning into partnerships that de‑risk innovation and compress time to market.

Market Access

Women's health: Predictions for 2026

A forward glance at new funding vehicles, national strategies, and innovative solutions reshaping the underlying infrastructure of women's care.

Market Access

VuuAI and Amiculum partner to transform content engagement i...

Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a GenAI-driven content production automation plat

Digital

Reimagining digital health partnerships: A practical guide f...

With billions invested and digital health initiatives on the rise, why do so few pharma-tech partnerships achieve lasting success?

R&D

How pharma companies can build mutually beneficial relations...

Seemingly every week, headlines declare new partnerships inked between global pharma giants and previously unknown start-ups.

Capital discipline in biotech: Building enduring companies w...

Closed & Collaborative H2 2025: Mergers, acquisitions, partn...

Women's health: Predictions for 2026

VuuAI and Amiculum partner to transform content engagement i...

Reimagining digital health partnerships: A practical guide f...

How pharma companies can build mutually beneficial relations...

ASCO: BMS hails "compelling" phase 3 celmod readout

Discover a new era of healthcare panel engagement: Grounded ...

Partnerships

Editor's Picks